Proteus study

• Research type

  Research Study

• Full title

  Prospective, randomized, multicentre, open label, phase II / III study to assess efficacy and safety of ranibizumab 0.5 mg intravitreal injections plus panretinal photocoagulation (PRP) versus PRP in monotherapy in the treatment of subjects with high risk proliferative diabetic retinopathy. (PROTEUS)

• IRAS ID

  143648

• Contact name

  Emily Fletcher

• Contact email

  Emily.Fletcher@glos.nhs.uk

• Sponsor organisation

  AIBILI - Association for Innovation and Biomedical Research on Light and Image

• Eudract number

  2013-003640-23

• ISRCTN Number

  n/a

• Clinicaltrials.gov Identifier

  n/a

• REC name

  West Midlands - Edgbaston Research Ethics Committee

• REC reference

  13/WM/0491

• Date of REC Opinion

  13 Jan 2014

• REC opinion

  Further Information Favourable Opinion